This inventor holds 4 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Accutar Biotechnology Inc., Tiger Biotherapeutics Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Ke Liu
Introduction
Ke Liu is a prominent inventor based in Bellevue, WA, known for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Liu has made strides in developing novel compounds that target critical pathways in disease treatment.
Latest Patents
Liu's latest patents include "Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors," which focuses on novel CDK inhibitors and their pharmaceutical applications in preventing and treating diseases associated with CDK. Another notable patent is "Compounds having BET, estrogen receptor, and androgen receptor degradation activity and uses thereof," which discloses compounds and their use in the prevention and treatment of cancer and related diseases.
Career Highlights
Throughout his career, Ke Liu has worked with reputable companies such as Tiger Biotherapeutics Inc. and Accutar Biotechnology Inc. His work has been instrumental in advancing therapeutic options in the pharmaceutical industry.
Collaborations
Liu has collaborated with notable colleagues, including Jie Fan and Wei He, contributing to a dynamic research environment that fosters innovation.
Conclusion
Ke Liu's work exemplifies the impact of innovative thinking in the pharmaceutical sector. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile